Overview

Dthera Sciences (OTCQB:DTHR), based in San Diego, Calif., is a digital therapeutics company focused on developing innovative quality of life therapies for the elderly and those suffering from cognitive decline. The Company’s lead product, ReminX, is an artificial-intelligence-powered consumer health product designed to deliver reminiscence therapy digitally to individuals suffering from dementia from Alzheimer’s disease and other neurodegenerative conditions, as well as for seniors experiencing social isolation. The company plans to launch ReminX commercially in the second quarter of 2018.

Company Profile

7310 Miramar Road Suite 350
San Diego CA, 92126

Tel: 858-215-6360

IR@dthera.com

Today

Intraday stock chart for DTHR

Leadership

Edward Cox

CEO

Dave Keene

CTO

View Management Team

Past Six Months

6 month stock chart for DTHR

Investor Relations

CORE IR
377 Oak Street
Garden City, NY 11530
Tel: 516-222-2560
www.coreir.com

Transfer Agent

Interwest Transfer Co., Inc.
1981 Murray Holladay Road
Suite 100
Salt Lake City, UT 84117
Tel: 801-272-9294
www.interwesttc.com

Auditors

Sadler Gibb & Associates
Certified Public Accountants
2455 East Parleys Way
Suite 320
Salt Lake City, UT 84109
Tel: 801-783-2950
http://www.sadlergibb.com

Corporate Counsel

Salt Lake City
Kirton McConkie Building
50 East South Temple
Suite 400
Salt Lake City, UT 84111
Tel: 801-328-3600
Fax: 801-321-4893

Subscribe to IR news and filing alerts

You can opt out at any time. We do not share or sell your info.